克隆-话题@MedSci

#克隆#

209篇内容 | 3320人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1660211, encodeId=e11516602117b, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Blood：亚克隆NT5C2突变与急性淋巴细胞白血病复发后的预后不良的相关性, objectType=article, longId=187564, objectId=83f918e56435, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83f918e56435, replyNumber=0, likeNumber=69, createdTime=2020-05-19, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83f918e56435, moduleTitle=Blood：亚克隆NT5C2突变与急性淋巴细胞白血病复发后的预后不良的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83f918e56435)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660193, encodeId=c85f166019385, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=2019 IMWG共识建议：单克隆浆细胞疾病的影像学检查, objectType=article, longId=167859, objectId=cfa116e8593d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfa116e8593d, replyNumber=0, likeNumber=24, createdTime=2019-08-29, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfa116e8593d, moduleTitle=2019 IMWG共识建议：单克隆浆细胞疾病的影像学检查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfa116e8593d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660200, encodeId=3c0a166020026, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=西安杨森宣布全球CD38单克隆抗体靶向药物兆珂(R)在中国上市, objectType=article, longId=181322, objectId=2ee818132282, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ee818132282, replyNumber=0, likeNumber=68, createdTime=2020-02-02, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ee818132282, moduleTitle=西安杨森宣布全球CD38单克隆抗体靶向药物兆珂(R)在中国上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ee818132282)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660203, encodeId=c5db166020302, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Clin Chem：免疫富集-偶联MALDI-TOF质谱法直接检测血清中单克隆游离轻链, objectType=article, longId=181586, objectId=ec6318158639, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec6318158639, replyNumber=0, likeNumber=51, createdTime=2020-09-24, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec6318158639, moduleTitle=Clin Chem：免疫富集-偶联MALDI-TOF质谱法直接检测血清中单克隆游离轻链, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec6318158639)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660215, encodeId=06c416602157c, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Blood：老年贫血个体的突变谱和克隆造血动态, objectType=article, longId=188121, objectId=de74188121e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de74188121e0, replyNumber=0, likeNumber=79, createdTime=2020-07-03, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de74188121e0, moduleTitle=Blood：老年贫血个体的突变谱和克隆造血动态, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de74188121e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660210, encodeId=de8d166021072, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Circulation：IL-6信号遗传缺陷可可降低克隆造血变异个体的心血管风险, objectType=article, longId=186901, objectId=d469186901c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d469186901c6, replyNumber=0, likeNumber=62, createdTime=2020-02-04, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d469186901c6, moduleTitle=Circulation：IL-6信号遗传缺陷可可降低克隆造血变异个体的心血管风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d469186901c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660198, encodeId=eda51660198f1, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Lancet oncol：Pegilodecakin联合抗PD-1单克隆抗体是否可为晚期实体肿瘤提供新的治疗机会？, objectType=article, longId=180124, objectId=a26018012453, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a26018012453, replyNumber=0, likeNumber=56, createdTime=2020-08-17, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a26018012453, moduleTitle=Lancet oncol：Pegilodecakin联合抗PD-1单克隆抗体是否可为晚期实体肿瘤提供新的治疗机会？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a26018012453)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660204, encodeId=4f5816602044a, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=天士力右佐匹克隆片获仿制药一致性评价, objectType=article, longId=181837, objectId=de8018183e17, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de8018183e17, replyNumber=0, likeNumber=57, createdTime=2019-11-22, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de8018183e17, moduleTitle=天士力右佐匹克隆片获仿制药一致性评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de8018183e17)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660189, encodeId=58701660189d0, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Blood：重编程与骨髓增生异常综合征的克隆进化阶段, objectType=article, longId=164914, objectId=ad071649145a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad071649145a, replyNumber=0, likeNumber=50, createdTime=2020-03-31, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad071649145a, moduleTitle=Blood：重编程与骨髓增生异常综合征的克隆进化阶段, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad071649145a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660194, encodeId=9719166019470, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=晚期恶性肿瘤的治疗：抗CD47单克隆抗体TJC4在中国启动临床试验, objectType=article, longId=175549, objectId=7fc31e5549df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fc31e5549df, replyNumber=0, likeNumber=0, createdTime=2020-05-07, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fc31e5549df, moduleTitle=晚期恶性肿瘤的治疗：抗CD47单克隆抗体TJC4在中国启动临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fc31e5549df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660184, encodeId=a17e1660184f1, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Blood：多发性骨髓瘤17p缺失的亚克隆比例越高，患者预后越差, objectType=article, longId=159620, objectId=014d159620e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=014d159620e4, replyNumber=0, likeNumber=63, createdTime=2019-12-30, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=014d159620e4, moduleTitle=Blood：多发性骨髓瘤17p缺失的亚克隆比例越高，患者预后越差, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=014d159620e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660202, encodeId=c583166020273, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Blood：研究调节克隆优势和骨髓纤维化机制的新模型, objectType=article, longId=181487, objectId=298f18148e93, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=298f18148e93, replyNumber=0, likeNumber=71, createdTime=2020-05-13, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=298f18148e93, moduleTitle=Blood：研究调节克隆优势和骨髓纤维化机制的新模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=298f18148e93)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660186, encodeId=d775166018640, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Neurology：抗PD-1单克隆抗体相关的神经肌肉不良事件, objectType=article, longId=162045, objectId=edda1620450c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edda1620450c, replyNumber=0, likeNumber=112, createdTime=2019-07-12, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edda1620450c, moduleTitle=Neurology：抗PD-1单克隆抗体相关的神经肌肉不良事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edda1620450c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660181, encodeId=ff95166018115, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=世界首批体细胞克隆疾病模型猴在中国诞生, objectType=article, longId=158796, objectId=b5ea158e960f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5ea158e960f, replyNumber=0, likeNumber=68, createdTime=2019-07-25, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5ea158e960f, moduleTitle=世界首批体细胞克隆疾病模型猴在中国诞生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5ea158e960f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660178, encodeId=70e316601e8c7, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=抗PD-1单克隆抗体达伯舒®（信迪利单抗注射液）在中国正式获批, objectType=article, longId=156858, objectId=0ef515685842, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ef515685842, replyNumber=0, likeNumber=76, createdTime=2019-03-13, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ef515685842, moduleTitle=抗PD-1单克隆抗体达伯舒®（信迪利单抗注射液）在中国正式获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ef515685842)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660190, encodeId=09a6166019056, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Blood：尿单克隆蛋白不是判定MM患者是否完全缓解的必要指标, objectType=article, longId=164916, objectId=416216491617, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=416216491617, replyNumber=0, likeNumber=50, createdTime=2020-01-10, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=416216491617, moduleTitle=Blood：尿单克隆蛋白不是判定MM患者是否完全缓解的必要指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=416216491617)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660197, encodeId=4b6f166019ee7, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=张会来教授：PD-1/PD-L1单克隆抗体在恶性淋巴瘤的研究方向与热点问题, objectType=article, longId=179922, objectId=9aec1e992277, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9aec1e992277, replyNumber=0, likeNumber=64, createdTime=2020-03-12, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9aec1e992277, moduleTitle=张会来教授：PD-1/PD-L1单克隆抗体在恶性淋巴瘤的研究方向与热点问题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9aec1e992277)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660185, encodeId=18ff16601859a, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Brit J Cancer：睾丸生殖细胞癌发展过程中分子异质性和早期转移克隆选择, objectType=article, longId=161195, objectId=78a316119549, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78a316119549, replyNumber=0, likeNumber=56, createdTime=2019-10-18, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78a316119549, moduleTitle=Brit J Cancer：睾丸生殖细胞癌发展过程中分子异质性和早期转移克隆选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78a316119549)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660199, encodeId=f9671660199e5, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=全新作用机制开创骨髓瘤治疗新时代西安杨森宣布全球CD38单克隆抗体靶向药物兆珂®在中国上市, objectType=article, longId=181286, objectId=6a1418128699, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a1418128699, replyNumber=0, likeNumber=66, createdTime=2020-01-09, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a1418128699, moduleTitle=全新作用机制开创骨髓瘤治疗新时代西安杨森宣布全球CD38单克隆抗体靶向药物兆珂®在中国上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a1418128699)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660195, encodeId=71db166019544, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Abcam收购EdiGene，获得2800多个单克隆敲除（KO）细胞系, objectType=article, longId=175684, objectId=e6441e56847c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6441e56847c, replyNumber=0, likeNumber=55, createdTime=2020-06-13, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6441e56847c, moduleTitle=Abcam收购EdiGene，获得2800多个单克隆敲除（KO）细胞系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6441e56847c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

克隆

2020-05-29

aids221 (审核中...)

前往app查看评论内容

#克隆#

Blood：亚克隆NT5C2突变与急性淋巴细胞白血病复发后的预后不良的相关性

2020-05-19

aids221 (审核中...)

前往app查看评论内容

#克隆#

2019 IMWG共识建议：单克隆浆细胞疾病的影像学检查

2019-08-29

aids221 (审核中...)

前往app查看评论内容

#克隆#

西安杨森宣布全球CD38单克隆抗体靶向药物兆珂(R)在中国上市

2020-02-02

aids221 (审核中...)

前往app查看评论内容

#克隆#

Clin Chem：免疫富集-偶联MALDI-TOF质谱法直接检测血清中单克隆游离轻链

2020-09-24

aids221 (审核中...)

前往app查看评论内容

#克隆#

Blood：老年贫血个体的突变谱和克隆造血动态

2020-07-03

aids221 (审核中...)

前往app查看评论内容

#克隆#

Circulation：IL-6信号遗传缺陷可可降低克隆造血变异个体的心血管风险

2020-02-04

aids221 (审核中...)

前往app查看评论内容

#克隆#

Lancet oncol：Pegilodecakin联合抗PD-1单克隆抗体是否可为晚期实体肿瘤提供新的治疗机会？

2020-08-17

aids221 (审核中...)

前往app查看评论内容

#克隆#

天士力右佐匹克隆片获仿制药一致性评价

2019-11-22

aids221 (审核中...)

前往app查看评论内容

#克隆#

Blood：重编程与骨髓增生异常综合征的克隆进化阶段

2020-03-31

aids221 (审核中...)

前往app查看评论内容

#克隆#

晚期恶性肿瘤的治疗：抗CD47单克隆抗体TJC4在中国启动临床试验

2020-05-07

aids221 (审核中...)

前往app查看评论内容

#克隆#

Blood：多发性骨髓瘤17p缺失的亚克隆比例越高，患者预后越差

2019-12-30

aids221 (审核中...)

前往app查看评论内容

#克隆#

Blood：研究调节克隆优势和骨髓纤维化机制的新模型

2020-05-13

aids221 (审核中...)

前往app查看评论内容

#克隆#

Neurology：抗PD-1单克隆抗体相关的神经肌肉不良事件

2019-07-12

aids221 (审核中...)

前往app查看评论内容

#克隆#

世界首批体细胞克隆疾病模型猴在中国诞生

2019-07-25

aids221 (审核中...)

前往app查看评论内容

#克隆#

抗PD-1单克隆抗体达伯舒®（信迪利单抗注射液）在中国正式获批

2019-03-13

aids221 (审核中...)

前往app查看评论内容

#克隆#

Blood：尿单克隆蛋白不是判定MM患者是否完全缓解的必要指标

2020-01-10

aids221 (审核中...)

前往app查看评论内容

#克隆#

张会来教授：PD-1/PD-L1单克隆抗体在恶性淋巴瘤的研究方向与热点问题

2020-03-12

aids221 (审核中...)

前往app查看评论内容

#克隆#

Brit J Cancer：睾丸生殖细胞癌发展过程中分子异质性和早期转移克隆选择

2019-10-18

aids221 (审核中...)

前往app查看评论内容

#克隆#

全新作用机制开创骨髓瘤治疗新时代西安杨森宣布全球CD38单克隆抗体靶向药物兆珂®在中国上市

2020-01-09

aids221 (审核中...)

前往app查看评论内容

#克隆#

Abcam收购EdiGene，获得2800多个单克隆敲除（KO）细胞系

2020-06-13

科室
- - 订阅+
  - 更多科室
工具
服务